Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126591411 | 12659141 | 1 | I | 20160727 | 20160817 | 20160817 | EXP | JP-PFIZER INC-2016365640 | PFIZER | 7.00 | DEC | F | Y | 0.00000 | 20160817 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126591411 | 12659141 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, WEEKLY | 0 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 126591411 | 12659141 | 2 | PS | RHEUMATREX | METHOTREXATE SODIUM | 1 | 6 MG, UNK | 11719 | 6 | MG | CAPSULE | ||||||||
| 126591411 | 12659141 | 3 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | 8 MG, UNK | 11719 | 8 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126591411 | 12659141 | 1 | Rheumatoid arthritis |
| 126591411 | 12659141 | 2 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126591411 | 12659141 | LT |
| 126591411 | 12659141 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126591411 | 12659141 | Lymphoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |